MedPath

TEVA-ATOVAQUONE PROGUANIL

TEVA-ATOVAQUONE PROGUANIL

Approved
DIN Number

02380927

Drug Class

Human

Market Date

Mar 1, 2012

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02380927
AIG Number0250721002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
P01BB51 PROGUANIL AND ATOVAQUONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:30.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

ATOVAQUONEActive
Strength: 250 MG
Monograph: ATOVAQUONE
PROGUANIL HYDROCHLORIDEActive
Strength: 100 MG
Monograph: PROGUANIL HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.